Skip to main content

Cephalon Expands R&D Lab Facilities

Published 4/6/2000

Cephalon  has a $5.5-million expansion and renovation project planned for its headquarters at the Brandywine Corporate Center to provide additional lab space for drug research and development. Cephalon owns three 50,000-sf buildings at the Center. One, which is currently unoccupied, will house 35,000 sf of new administrative offices, releasing more space for labs in the other two buildings. The biotechnology company anticipated completion of the renovation by late summer 2000.